Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT03633552 : Efficacy of Two Temozolomide Regimens in Adjuvant Treatment of Patients With Brain High Grade Glioma
PhasePhase 3
AgesMin: 18 Years Max: 70 Years
Eligibility
Inclusion Criteria:

- Newly diagnosed glioblastoma and anaplastic astrocytoma

- age between 18 and 70 years

- Karnofsky Performance Scale Index equal or more than 60 percent

- signed informed consent

Exclusion Criteria:

- chronic hepatic

- renal failure

- cardiac failure

- history of hematologic malignancies
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT03633552      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740